Lixte Biotechnology H -CW25LIXTWPreferred / convertible
13F holders, Q3 2024 (September 30)3holders −2
0new positions
2sold out
1famous investor
$0.05avg. 13F price*
At the end of Q3 2024, 3 institutions reported holding Lixte Biotechnology H -CW25 (LIXTW) in their 13F filings, down 2 from Q2 2024. 0 opened new positions and 2 sold out. The largest holders were Warberg Asset Management LLC ($2K), Citadel Advisors ($1K) and Clear Street LLC ($922). One famous investor held it Ken Griffin ( of Citadel Advisors's portfolio).
- Company
- Lixte Biotechnology H -CW25
- CUSIP
- 539319111
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $3K |
All 13F filers, Q2 2024 → Q3 2024: 52,742 shares sold, net −52,742 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Warberg Asset Management LLC | — | Reduce -5.2% | 35,906 | $2K |
| Citadel Advisors | — | Reduce -12.4% | 28,141 | $1K |
| Clear Street LLC | — | Reduce -2.6% | 22,554 | $922 |
"% of holder's portfolio" is LIXTW's weight in each manager's 13F, not the share of Lixte Biotechnology H -CW25 the manager owns.